Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan

January 6, 2015 2:58 PM

10 7

A deal being announced today with Genentech points the way for 23andMe, the personal genetics company backed by Facebook billionaire Yuri Milner and Google Ventures to become a sustainable business – even if the company’s discussions with the U.S. Food and Drug Administration stretch on for years.

According to sources close to the deal, 23andMe is receiving an upfront payment from Genentech of $10 million, with further milestones of as much as $50 million. The deal is the first of ten 23andMe says it has signed with large pharmaceutical and biotech companies.

Also read: Kanye West won’t be released from the hospital Monday as originally planned

Read more

To category page

Loading...